Native human bombesin receptor subtype 3 has a unique pharmacology

Samuel A. Mantey; Richard M. Ryan; H. Christian Weber; Tapas K. Pradhan; D. H. Coy

doi:10.1016/s0016-5085(98)84724-0

Related publications

Article1998

The bombesin receptor subtype 4 is coupled to phospholipase C and has a unique pharmacology

Tapas K. Pradhan, Tatsuro Katsuno, Richard M. Ryan, Samuel A. Mantey, Mark Akeson, Patrick J. Donohue, J.F. Battey

Gastroenterology

Article1998

Pharmacology and intracellular signaling of the human bombesin receptor subtype 3

Richard M. Ryan, H. Christian Weber, Samuel A. Mantey, Tapas K. Pradhan, Wei Hou, D. H. Coy, R. T. Jensen

Gastroenterology

Article1998

Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes

Tapas K. Pradhan, Tatsuro Katsuno, John E. Taylor, Sun H. Kim, Richard M. Ryan, Samuel A. Mantey, Patrick J. Donohue, H. Christian Weber, Eduardo Sainz, James F. Battey, David H. Coy, Robert T. Jensen

European Journal of Pharmacology

Article1999

Pharmacology and Cell Biology of the Bombesin Receptor Subtype 4 (BB<sub>4</sub>-R)

Tatsuro Katsuno, Tapas K. Pradhan, Richard M. Ryan, Samuel A. Mantey, Wei Hou, Patrick J. Donohue, Mark Akeson, Eliot R. Spindel, James F. Battey, David H. Coy, Robert T. Jensen

Biochemistry

Article1990

Pharmacological profile of ICI 216140, a novel bombesin antagonist

A. Cowan, James L. Daniel, Richard M. Ryan, Helen Wheeler-Aceto

European Journal of Pharmacology

Native human bombesin receptor subtype 3 has a unique pharmacology

Abstract

Discussion(0)

Related publications

The bombesin receptor subtype 4 is coupled to phospholipase C and has a unique pharmacology

Pharmacology and intracellular signaling of the human bombesin receptor subtype 3

Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes

Pharmacology and Cell Biology of the Bombesin Receptor Subtype 4 (BB<sub>4</sub>-R)

Pharmacological profile of ICI 216140, a novel bombesin antagonist